Coalition for the Reversal of Breast Cancer Mortality in African American Women

A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond

Thursday, August 28, 2014

DEEP INTO THE BOWEL OF EPIGENIC PHENOMENA

›
Deep into the bowel of epigenic phenomena dances important genes dances RuvB-like 1 gene, a gene so important it may have been borrowed or...
Tuesday, August 26, 2014

Thoughts about a Novel approach to cancer treatment

›
With the success of PDL-1/PD-1 and the suspicion that cancer cells build mechanisms to escape natural immunity from inducing Apoptosis at ...

WHEN YOU ARE GOOD, YOU COULD BE EXCELLENT: THE CASE OF VELCADE

›
SOURCE FDA/MEDSCAPE "The U.S. Food and Drug Administration has approved Velcade (bortezomib) for the retreatment of adult patients ...

CRBCM IS GLAD TO HEAR DR MUYEMBE TAMFUM IS HEADING TO LIBERIA FOR THE EBOLA OUTBREAK THERE!

›
DR MUYEMBE, WAS FIRST MY MICROBIOLOGY PROFESSOR AND WAS DEAN OF THE MEDICAL SCHOOL WHILE 1 WAS STILL A STRUGGLING MEDICAL STUDENT, IT IS GO...

And life goes on

›
Dear Mutombo Kankonde, Congratulations! Your application to host TEDMED Live has been accepted! We are able to offer you this opportunity...
Monday, August 25, 2014

Unveiling the Cytokines!

›
It is increasingly suggested that the role of what we call the Cytokines, once looked at closely, is much broader and remains one of the ins...
Friday, August 22, 2014

Focus of the RCC1 gene

›
RCC1----Crm1--- Ran guanine nucleotide exchange factor according to Nemergut:" RanBP3 acts as a scaffold protein to promote the effici...

No CPRIT No Problem!

›
We have submitted all kinds of research projects we have tried to compete, we have teased congressmen we have met all kinds of people who ...

To not waste time

›
At least 2 projects that will get funding from CPRIT will join ideas developed here already and have been addressed here.  the MDM-2 as a so...
Thursday, August 21, 2014

Shifting sand!

›
Until we define clear biomarkers, Lupus and related autoimmune diseases will remain shifting sands, and experts don't help either, just ...

And CPRIT Continua

›
The new CPRIT round of grants have been given and nominated one thing for sure, they are just as diverse as they can be and went to the us...
Wednesday, August 20, 2014

reflexion at CRBCM!

›
What if the Universe was a man, a living giant organism, how can we talk to this man! how can we make our voice heard? Is it important? wha...

Je disais que: DCK gene: lack of this gene protect most dangerous cancers!

›
An important pathway is what actually matter, has clinical relevance and plays an important role. In Cancers, what may impact clinical outco...
Saturday, August 16, 2014

JUST AS YOU THOUGHT YOU HAVE SEEN ALL ABOUT AVASTIN!

›
BEVACIZUMAB HAS BEEN APPROVED FOR METASTATIC CERVICAL CANCER IN COMBINATION WITH TOPOTECAN TAXOL AND CISPLATIN BECAUSE OF INCREASE IN OVERAL...

CRBCM ON THE ROAD AGAIN, continuing to meet its requirements!

›
Hi Dr. Kankonde, I have everything booked for your assignment starting August 18, 2014. Below is the detailed information you will need...
Wednesday, August 13, 2014

Keep on asking myself!

›
"Lucitanib has 50% Response (PR) in FGF-amplified Breast Cancer" given FGF amplification requirement, and the involvement of Hepa...

questions?

›
From ASCO, for Extensive disease, CISPLATIN -  Etoposide has become standard of care but in Bulky Mediastinal disease, new study propose R...
Monday, August 11, 2014

Facts: SOME POSITIVE TRIALS! (from ASCO)

›
*Multicenter phase II trial in RECURRENT Ovarian Cancer Cediranib 30 mg daily + Olaprib 200mg PO BID   Vs   Olaparib 400 mg BID POSITIVE T...
Sunday, August 10, 2014

Most unpredictable compounds: the cytokines!

›
They are numerous, most insidious and varied, yet impact the trends of our life in a deep, multiple ways.  And we are just now trying to dig...
Thursday, August 7, 2014

Major advances in Oncology. and CRBCM on the move!

›
1.In lung cancer, Pembrolizumab, the PD-1 humanized antibody made the Breakthrough cut but keeping activity in first line as well advanced N...
Sunday, August 3, 2014

Good update to have in hematologic malignancy, and may be a chance to visit the POLO-like kinases! take a plunge!

›
CONTINUING MEDICAL EDUCATION CERTIFICATE certifies that Mutombo Kankonde, MD 2400 Trawood Drive Suite 303 El Paso, TX ...

Big good

›
CONTINUING MEDICAL EDUCATION CERTIFICATE certifies that Mutombo Kankonde, MD 2400 Trawood Drive Suite 303...
Thursday, July 31, 2014

With Anti-PD1, and Ibrutinib, we have entered the new world of therapy in cancers

›
The time of dirty bomb that standard Chemotherapy represented, has quickly led to major side effects and of course given us partial results....
Monday, July 28, 2014

Interesting find in the literature, not from CRBCM but tie our life up completely!

›
 This can be found in the literature 110 interacting genes: ACTG1 ACTN2 AGTPBP1 ...

Medicine of the future!

›
Medicine of the future The way we see it, in the near future, 3 main factors will determine what will be driving medicine in the future. ...
Sunday, July 27, 2014

working hard to meet the needs of our patients

›
...

Hitch a hike towards a comprehensive Cytokine Bank and Manufacturing Unit

›
The Protein Data Bank funded by several great institutions is a good starting point: http://www.rcsb.org/pdb/home/home.do
Saturday, July 26, 2014

Attending the annual national Grifols Talecris Medical Directors Conference in Seattle

›

Health Fairs help increase the awareness of the value of PREVENTION !

›

›
CRBCM & Greater East Cancer Center participating in the Aliviane/YWCA Health Fair in El Paso TX, 07/26/20114 App...
‹
›
Home
View web version

Steering Committee

Peggy Kankonde
View my complete profile
Powered by Blogger.